646 | Data Patterns IPO Analysis by Yes securities Ltd | Yes securities Ltd | Apply | IPO |
16 | RailTel IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Not Rated | IPO |
47 | Indigo Paints IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
59 | Home First Finance IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
107 | EaseMyTrip IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
124 | Craftsman Automation IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
178 | Lodha Developers IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Not Rated | IPO |
190 | Shyam Metalics IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
214 | Sona Comstar IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
245 | India Pesticides IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Not Rated | IPO |
269 | G R Infraprojects IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Not Rated | IPO |
289 | Clean Science IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
304 | Glenmark Life Sciences IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
315 | Zomato IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
325 | Tatva Chintan Pharma IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
347 | Rolex Rings IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
409 | CarTrade Tech IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Neutral | IPO |
428 | Aptus Value Housing Finance IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Neutral | IPO |
459 | Vijaya Diagnostic IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
496 | Paras Defence and Space Technologies IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
512 | Fino Payments Bank IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
522 | SJS Enterprises IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Neutral | IPO |
557 | Sapphire Foods IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
645 | Data Patterns IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Not Rated | IPO |
667 | Medplus Health IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
151 | Kalyan Jewellers IPO Analysis by Swastika Investmart Ltd | Swastika Investmart Ltd | Avoid | IPO |
537 | Nykaa IPO Analysis by Swastika Investmart Ltd | Swastika Investmart Ltd | Apply | IPO |
577 | GoColors IPO Analysis by Swastika Investmart Ltd | Swastika Investmart Ltd | Apply | IPO |
45 | Indigo Paints IPO Analysis by Sushil Finance Ltd | Sushil Finance Ltd | Not Rated | IPO |
123 | Craftsman Automation IPO Analysis by Sushil Finance Ltd | Sushil Finance Ltd | Not Rated | IPO |
131 | Laxmi Organic IPO Analysis by Sushil Finance Ltd | Sushil Finance Ltd | Not Rated | IPO |
288 | Clean Science IPO Analysis by Sushil Finance Ltd | Sushil Finance Ltd | Neutral | IPO |
302 | Glenmark Life Sciences IPO Analysis by Sushil Finance Ltd | Sushil Finance Ltd | Apply | IPO |
25 | IRFC IPO Analysis by StockEdge | StockEdge | Not Rated | IPO |
244 | India Pesticides IPO Analysis by StockEdge | StockEdge | Not Rated | IPO |
442 | Ami Organics IPO Analysis by StockEdge | StockEdge | Neutral | IPO |
494 | Paras Defence and Space Technologies IPO Analysis by StockEdge | StockEdge | Neutral | IPO |
44 | Indigo Paints IPO Analysis by Spark Capital | Spark Capital | Apply | IPO |
14 | RailTel IPO Analysis by SMC Global | SMC Global | Apply | IPO |
122 | Craftsman Automation IPO Analysis by SMC Global | SMC Global | Neutral | IPO |
166 | Barbeque Nation IPO Analysis by SMC Global | SMC Global | Neutral | IPO |
177 | Lodha Developers IPO Analysis by SMC Global | SMC Global | Neutral | IPO |
301 | Glenmark Life Sciences IPO Analysis by SMC Global | SMC Global | May apply | IPO |
371 | Exxaro Tiles IPO Analysis by SMC Global | SMC Global | Apply | IPO |
470 | Sansera Engineering IPO Analysis by SMC Global | SMC Global | Neutral | IPO |
43 | Indigo Paints IPO Analysis by Sharekhan Limited | Sharekhan Limited | Not Rated | IPO |
84 | Heranba Industries IPO Analysis by Sharekhan Limited | Sharekhan Limited | Not Rated | IPO |
213 | Sona Comstar IPO Analysis by Sharekhan Limited | Sharekhan Limited | Not Rated | IPO |
268 | G R Infraprojects IPO Analysis by Sharekhan Limited | Sharekhan Limited | Not Rated | IPO |
287 | Clean Science IPO Analysis by Sharekhan Limited | Sharekhan Limited | Not Rated | IPO |
314 | Zomato IPO Analysis by Sharekhan Limited | Sharekhan Limited | Neutral | IPO |
323 | Tatva Chintan Pharma IPO Analysis by Sharekhan Limited | Sharekhan Limited | Neutral | IPO |
391 | Devyani International IPO Analysis by Sharekhan Limited | Sharekhan Limited | Neutral | IPO |
476 | Aditya Birla Sun Life AMC IPO Analysis by Sharekhan Limited | Sharekhan Limited | Neutral | IPO |
105 | EaseMyTrip IPO Analysis by S P Tulsian | S P Tulsian | Apply | IPO |
42 | Indigo Paints IPO Analysis by Religare Broking Limited | Religare Broking Limited | Not Rated | IPO |
176 | Lodha Developers IPO Analysis by Religare Broking Limited | Religare Broking Limited | Not Rated | IPO |
243 | India Pesticides IPO Analysis by Religare Broking Limited | Religare Broking Limited | Not Rated | IPO |
267 | G R Infraprojects IPO Analysis by Religare Broking Limited | Religare Broking Limited | Not Rated | IPO |
313 | Zomato IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
338 | Paytm IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
390 | Devyani International IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
427 | Aptus Value Housing Finance IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
457 | Vijaya Diagnostic IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
469 | Sansera-Engineering-Ltd-IPO-Note-Religare-Broking | Religare Broking Limited | Neutral | IPO |
493 | Paras Defence and Space Technologies IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
510 | Fino Payments Bank IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
521 | SJS Enterprises IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
536 | Nykaa IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
589 | Star Health IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
605 | Tega Industries IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
13 | RailTel IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
41 | Indigo Paints IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
69 | Brookfield India REIT Analysis by Reliance Securities | Reliance Securities | May apply | IPO |
73 | Nureca limited IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
146 | Anupam Rasayan IPO Analysis by Reliance Securities | Reliance Securities | Not Rated | IPO |
175 | Lodha Developers IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
242 | India Pesticides IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
266 | G R Infraprojects IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
286 | Clean Science IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
322 | Tatva Chintan Pharma IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
337 | Paytm IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
346 | Rolex Rings IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
370 | Exxaro Tiles IPO Analysis by Reliance Securities | Reliance Securities | Neutral | IPO |
456 | Vijaya Diagnostic IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
492 | Paras Defence and Space Technologies IPO Analysis by Reliance Securities | Reliance Securities | Neutral | IPO |
509 | Fino Payments Bank IPO Analysis by Reliance Securities | Reliance Securities | Neutral | IPO |
576 | GoColors IPO Analysis by Reliance Securities | Reliance Securities | Neutral | IPO |
83 | Heranba Industries IPO Analysis by Prabhudas Lilladher Pvt Ltd | Prabhudas Lilladher Pvt Ltd | Apply | IPO |
121 | Craftsman Automation IPO Analysis by Prabhudas Lilladher Pvt Ltd | Prabhudas Lilladher Pvt Ltd | May apply | IPO |
130 | Laxmi Organic IPO Analysis by Prabhudas Lilladher Pvt Ltd | Prabhudas Lilladher Pvt Ltd | Apply | IPO |
165 | Barbeque Nation IPO Analysis by Prabhudas Lilladher Pvt Ltd | Prabhudas Lilladher Pvt Ltd | Apply | IPO |
198 | POWERGRID InvIT IPO April 2021 Analysis by Prabhudas Lilladher Pvt Ltd | Prabhudas Lilladher Pvt Ltd | Apply | IPO |
241 | India Pesticides IPO Analysis by Prabhudas Lilladher Pvt Ltd | Prabhudas Lilladher Pvt Ltd | Apply | IPO |
265 | G R Infraprojects IPO Analysis by Prabhudas Lilladher Pvt Ltd | Prabhudas Lilladher Pvt Ltd | Apply | IPO |
389 | Devyani International IPO Analysis by Prabhudas Lilladher Pvt Ltd | Prabhudas Lilladher Pvt Ltd | Apply | IPO |
535 | Nykaa IPO Analysis by Prabhudas Lilladher Pvt Ltd | Prabhudas Lilladher Pvt Ltd | Apply | IPO |
24 | IRFC IPO Analysis by Phillip Capital | Phillip Capital | Apply | IPO |
264 | G R Infraprojects IPO Analysis by Phillip Capital | Phillip Capital | Apply | IPO |
40 | Indigo Paints IPO Analysis by Nirmal Bang | Nirmal Bang | Not Rated | IPO |
58 | Home First Finance IPO Analysis by Nirmal Bang | Nirmal Bang | Apply | IPO |
164 | Barbeque Nation IPO Analysis by Nirmal Bang | Nirmal Bang | Apply | IPO |
212 | Sona Comstar IPO Analysis by Nirmal Bang | Nirmal Bang | Apply | IPO |
263 | G R Infraprojects IPO Analysis by Nirmal Bang | Nirmal Bang | Apply | IPO |
388 | Devyani International IPO Analysis by Nirmal Bang | Nirmal Bang | Apply | IPO |
407 | CarTrade Tech IPO Analysis by Nirmal Bang | Nirmal Bang | Apply | IPO |
475 | Aditya Birla Sun Life AMC IPO Analysis by Nirmal Bang | Nirmal Bang | Apply | IPO |
508 | Fino Payments Bank IPO Analysis by Nirmal Bang | Nirmal Bang | Apply | IPO |
547 | PolicyBazaar IPO Analysis by Nirmal Bang | Nirmal Bang | Neutral | IPO |
565 | Tarsons Products IPO Analysis by Nirmal Bang | Nirmal Bang | Apply | IPO |
614 | Anand Rathi IPO Analysis by Nirmal Bang | Nirmal Bang | Apply | IPO |
627 | MapmyIndia IPO Analysis by Nirmal Bang | Nirmal Bang | Apply | IPO |
644 | Data Patterns IPO Analysis by Nirmal Bang | Nirmal Bang | Apply | IPO |
655 | Metro Brands IPO Analysis by Nirmal Bang | Nirmal Bang | Apply | IPO |
670 | Supriya Lifescience IPO Analysis by Nirmal Bang | Nirmal Bang | Apply | IPO |
336 | Paytm IPO Analysis by Multi-Act Equity Consultancy Pvt Ltd | Multi-Act Equity Consultancy Pvt Ltd | Neutral | IPO |
57 | Home First Finance IPO Initiating Coverage by Motilal Oswal | Motilal Oswal | Not Rated | IPO |
92 | MTAR Technologies IPO Analysis by Motilal Oswal | Motilal Oswal | May apply | IPO |
145 | Anupam Rasayan IPO Analysis by Motilal Oswal | Motilal Oswal | Apply | IPO |
211 | Sona Comstar IPO Analysis by Motilal Oswal | Motilal Oswal | May apply | IPO |
240 | India Pesticides IPO Analysis by Motilal Oswal | Motilal Oswal | Apply | IPO |
321 | Tatva Chintan Pharma IPO Analysis by Motilal Oswal | Motilal Oswal | Apply | IPO |
406 | CarTrade Tech IPO Analysis by Motilal Oswal | Motilal Oswal | Apply | IPO |
441 | Ami Organics IPO Analysis by Motilal Oswal | Motilal Oswal | Apply | IPO |
534 | Nykaa IPO Analysis by Motilal Oswal | Motilal Oswal | Apply | IPO |
626 | MapmyIndia IPO Analysis by Motilal Oswal | Motilal Oswal | Apply | IPO |
643 | Data Patterns IPO Analysis by Motilal Oswal | Motilal Oswal | Apply | IPO |
23 | IRFC IPO Analysis by Monarch Networth Capital Limited | Monarch Networth Capital Limited | Apply | IPO |
455 | Vijaya Diagnostic IPO Analysis by Mehta Equities | Mehta Equities | Apply | IPO |
440 | Ami Organics IPO Analysis by Marwadi Shares and Finance Limited | Marwadi Shares and Finance Ltd | Apply | IPO |
454 | Vijaya Diagnostic IPO Analysis by Marwadi Shares and Finance Limited | Marwadi Shares and Finance Ltd | Apply | IPO |
468 | Sansera Engineering IPO Analysis by Marwadi Shares and Finance Limited | Marwadi Shares and Finance Ltd | Apply | IPO |
491 | Paras Defence and Space Technologies IPO Analysis by Marwadi Shares and Finance Limited | Marwadi Shares and Finance Ltd | Apply | IPO |
507 | Fino Payments Bank IPO Analysis by Marwadi Shares and Finance Limited | Marwadi Shares and Finance Ltd | Apply | IPO |
520 | SJS Enterprises IPO Analysis by Marwadi Shares and Finance Limited | Marwadi Shares and Finance Ltd | Apply | IPO |
533 | Nykaa IPO Analysis by Marwadi Shares and Finance Limited | Marwadi Shares and Finance Ltd | Apply | IPO |
546 | PolicyBazaar IPO Analysis by Marwadi Shares and Finance Limited | Marwadi Shares and Finance Ltd | Avoid | IPO |
552 | Sigachi Industries IPO Analysis by Marwadi Shares and Finance Limited | Marwadi Shares and Finance Ltd | Apply | IPO |
588 | Star Health IPO Analysis by Marwadi Shares and Finance Limited | Marwadi Shares and Finance Ltd | Avoid | IPO |
604 | Tega Industries IPO Analysis by Marwadi Shares and Finance Limited | Marwadi Shares and Finance Ltd | Apply | IPO |
613 | Anand Rathi IPO Analysis by Marwadi Shares and Finance Limited | Marwadi Shares and Finance Ltd | Apply | IPO |
625 | MapmyIndia IPO Analysis by Marwadi Shares and Finance Ltd | Marwadi Shares and Finance Ltd | Apply | IPO |
634 | RateGain IPO Analysis by Marwadi Shares and Finance Ltd | Marwadi Shares and Finance Ltd | Avoid | IPO |
642 | Data Patterns IPO Analysis by Marwadi Shares and Finance Ltd | Marwadi Shares and Finance Ltd | May apply | IPO |
649 | Shriram Properties IPO Analysis by Marwadi Shares and Finance Ltd | Marwadi Shares and Finance Ltd | Avoid | IPO |
654 | Metro Brands IPO Analysis by Marwadi Shares and Finance Ltd | Marwadi Shares and Finance Ltd | Apply | IPO |
659 | HP Adhesive IPO Analysis by Marwadi Shares and Finance Ltd | Marwadi Shares and Finance Ltd | Apply | IPO |
665 | Medplus Health IPO Analysis by Marwadi Shares and Finance Ltd | Marwadi Shares and Finance Ltd | Apply | IPO |
335 | Paytm IPO Pre-Listing Analysis by Macquarie Research | Macquarie Research | Avoid | IPO |
285 | Clean Science IPO Analysis by LKP Securities Ltd | LKP Securities Ltd | Apply | IPO |
12 | RailTel IPO Analysis by KR Choksey Securities Ltd | KR Choksey Securities Ltd | Apply | IPO |
68 | Brookfield India REIT Analysis by KR Choksey Securities Ltd | KR Choksey Securities Ltd | Apply | IPO |
210 | Sona Comstar IPO Analysis by KR Choksey Securities Ltd | KR Choksey Securities Ltd | Apply | IPO |
312 | Zomato IPO Analysis by KR Choksey Securities Ltd | KR Choksey Securities Ltd | Apply | IPO |
320 | Tatva Chintan Pharma IPO Analysis by KR Choksey Securities Ltd | KR Choksey Securities Ltd | Apply | IPO |
345 | Rolex Rings IPO Analysis by KR Choksey Securities Ltd | KR Choksey Securities Ltd | Apply | IPO |
360 | Nuvoco IPO Analysis by KR Choksey Securities Ltd | KR Choksey Securities Ltd | Apply | IPO |
415 | Krsnaa Diagnostics IPO Analysis by KR Choksey Securities Ltd | KR Choksey Securities Ltd | Apply | IPO |
453 | Vijaya Diagnostic IPO Analysis by KR Choksey Securities Ltd | KR Choksey Securities Ltd | Apply | IPO |
11 | RailTel IPO Analysis by Kotak Securities | Kotak Securities | Not Rated | IPO |
39 | Indigo Paints IPO Analysis by Kotak Securities | Kotak Securities | Not Rated | IPO |
163 | Barbeque Nation IPO Analysis by Kotak Securities | Kotak Securities | Not Rated | IPO |
188 | Shyam Metalics IPO Analysis by Kotak Securities | Kotak Securities | Not Rated | IPO |
197 | POWERGRID InvIT IPO April 2021 Analysis by Kotak Securities | Kotak Securities | Not Rated | IPO |
209 | Sona Comstar IPO Analysis by Kotak Securities | Kotak Securities | Not Rated | IPO |
439 | Ami Organics IPO Analysis by Kotak Securities | Kotak Securities | Neutral | IPO |
452 | Vijaya Diagnostic IPO Analysis by Kotak Securities | Kotak Securities | Neutral | IPO |
467 | Sansera Engineering IPO Analysis by Kotak Securities | Kotak Securities | Neutral | IPO |
603 | Tega Industries IPO Analysis by Kotak Securities | Kotak Securities | Neutral | IPO |
612 | Anand Rathi IPO Analysis by Kotak Securities | Kotak Securities | Neutral | IPO |
38 | Indigo Paints IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | May apply | IPO |
104 | EaseMyTrip IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Not Rated | IPO |
262 | G R Infraprojects IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Not Rated | IPO |
284 | Clean Science IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Not Rated | IPO |
369 | Exxaro Tiles IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
374 | Windlas Biotech IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
387 | Devyani International IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
405 | CarTrade Tech IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
414 | Krsnaa Diagnostics IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
451 | Vijaya Diagnostic IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
466 | Sansera-Engineering IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
474 | Aditya Birla Sun Life AMC IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
490 | Paras Defence and Space Technologies IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
519 | SJS Enterprises IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
532 | Nykaa IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
551 | Sigachi Industries IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
575 | GoColors IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
587 | Star Health IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
624 | MapmyIndia IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
633 | RateGain IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
15 | RailTel IPO Analysis by InvestorGain.com | InvestorGain.com | May apply | IPO |
26 | IRFC IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
46 | Indigo Paints IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
74 | Nureca limited IPO Analysis by InvestorGain.com | InvestorGain.com | Avoid | IPO |
93 | MTAR Technologies IPO Analysis by InvestorGain.com | InvestorGain.com | May apply | IPO |
106 | EaseMyTrip IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
132 | Laxmi Organic IPO Analysis by InvestorGain.com | InvestorGain.com | May apply | IPO |
189 | Shyam Metalics IPO Analysis by InvestorGain.com | InvestorGain.com | May apply | IPO |
303 | Glenmark Life Sciences IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
324 | Tatva Chintan Pharma IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
1 of 4 Next Last |